Robinhood Markets heads into its July 29 earnings report with two narratives running in opposite directions — one driven by the most bullish analyst setup in the market, the other by a CEO who sold aggressively into the rally.
The short interest picture has quietly shifted. Bears have rebuilt positions over the past month, with short interest climbing to 5.1% of the free float — up roughly 6% from 30 days ago, and nudging higher again this week by about 1%. That's not an extreme level, but the direction matters: shorts have been adding consistently since mid-June, coinciding almost precisely with the stock's 34% one-month surge. The borrow market, however, offers shorts no friction to worry about. Availability is deep — over 1,100% of short interest — meaning there are roughly eleven shares available to borrow for every one already lent out. Cost to borrow is negligible at 0.48%. Shorts are building, but they're doing so cheaply and freely. Options sentiment is equally calm: the put/call ratio at 0.63 is right on top of its 20-day average, with a z-score close to zero. Neither options traders nor the borrow market are signalling stress in either direction.
The Street is a different story entirely. The analyst recommendation differential ranks in the 99th percentile — as one-sided a consensus view as you'll find anywhere. Targets have moved up at virtually every firm that touched the name in the past fortnight. Barclays lifted to $122 from $82. Morgan Stanley raised to $124 from $95, even while staying at Equal-Weight. Goldman's Buy carries a $121 target. Mizuho is the most constructive at $130. The consensus mean of $117 now sits just above the current price of $111.97, which means the Street's collective target has been swallowed by the rally. On valuation, the trailing P/E has expanded to 45x — up more than 11 points over the past 30 days — and price-to-book has moved to 9.6x. Bulls point to AI-driven product expansion, the Trump Accounts initiative, and partnerships with BNY and TradePMR as evidence the platform is evolving beyond a trading app. Bears flag that the valuation now prices in substantial execution, and that regulatory risk hasn't disappeared just because sentiment improved.
The insider data adds a layer of tension the analyst upgrades don't explain away. CEO Vladimir Tenev sold over 356,000 shares on July 6 across multiple tranches priced between $113 and $118 — totalling roughly $41 million in a single day. Chief Legal Officer Daniel Gallagher also sold that day, in smaller volume. The 90-day net insider position is technically positive at around 739,000 shares, but that figure is flattering — much of it predates the recent price surge, and the July 6 selling cluster represents some of the most concentrated insider supply the stock has seen at these price levels. Tenev remains a top-5 holder with 54.5 million shares, so these are scale-management sales rather than a vote of no confidence, but the timing — into a 33% monthly move — is hard to ignore. BlackRock added modestly in the most recent period, providing some institutional ballast.
Among closely correlated peers, COIN and ETOR both fell roughly 3-4% on the week while IBKR edged up 3%. HOOD itself is down just 0.7% on the week, which is relative resilience — but the previous two earnings prints delivered single-day moves of -8.7% and -15.2% respectively. The July 29 report is where the analyst consensus, the insider selling, and the rebuilding short base will all be stress-tested at once.
See the live data behind this article on ORTEX.
Open HOOD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
